Headshot of Harold (Harv) I. Feldman, MD, MSCE, PCORI's first Deputy Executive Director for Patient-Centered Research Programs

Harold (Harv) I. Feldman, M.D., MSCE, M.S.Ed., is Deputy Executive Director for Patient-Centered Research Programs at the Patient-Centered Outcomes Research Institute (PCORI).

In this role, Feldman oversees an array of activities at PCORI, including funding research studies and research-related projects, engaging the healthcare community in PCORI’s work, and advancing dissemination and implementation of research findings.

Feldman brings to PCORI experiences from 35 years as an epidemiologist, nephrologist, and leader in numerous senior roles at the University of Pennsylvania (Penn), nationally, and globally. From 2012 to 2019, he served as chair of Penn’s largest basic science department, the Department of Biostatistics, Epidemiology, and Informatics (DBEI), having established Penn’s first Division of Informatics. His tri-disciplinary department was created to understand the social, cultural, behavioral, and biological determinants of health within a highly collaborative culture of scholarship.

Feldman also served as Director of Penn’s Center for Clinical Epidemiology and Biostatistics (CCEB) from 2012 until he joined PCORI in 2022. The CCEB houses seven centers of research excellence, a nationally renowned master’s degree program in Clinical Epidemiology, and two highly successful research support centers that support many of the National Institutes of Health (NIH)’s largest multi-center network research programs.

Feldman is also past President of the American College of Epidemiology, North America’s only professional credentialing organization for epidemiology that promotes the field through education, advocacy, and training. He is also in his second five-year term as Editor-in-chief of North America’s highest-impact scientific journal for clinical research in nephrology, the American Journal of Kidney Diseases.

Over the past three decades, Feldman has developed and led numerous educational programs for clinical researchers at the pre- and post-doctoral levels, such as Penn’s Master of Science in Clinical Epidemiology and its Robert Wood Johnson Clinical Scholars Program (CSP). He has also devoted himself to mentoring dozens of trainees (from the United States and abroad), junior faculty, and peers.

In parallel with his educational and academic leadership roles, Feldman built a nationally and internationally renowned research program in nephrology that has been a centerpiece of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)’s kidney-focused clinical research portfolio for over 20 years. It included the CRIC Study, the nation’s largest clinical follow-up study of chronic kidney disease, often referred to as the Framingham Study of kidney disease.

Feldman’s scholarship of more than 300 peer-reviewed scientific articles has been broad and far-reaching with many contributions to the understanding of extreme racial and ethnic disparities in kidney health that disproportionately plague our Black, Brown, Native American, and Latino/a communities. His program has been replicated around the globe—for example, in Japan, Germany, and India—and in 2010, he established and led an international network of chronic kidney disease epidemiology research programs, a role which he held for more than a decade.

While at Penn, Feldman was honored with numerous awards including for teaching, research, and mentoring. In addition to this recognition, he has been elected to membership in the American Society of Clinical Investigation, the Association of American Physicians, and the American Epidemiological Society.

Conflicts of Interest

As of June 23, 2023

Financial or Business Associations:

  • National Kidney Foundation, Editor, Self

Personal Associations:

  • International Society of Nephrology, Active Volunteer, Self


Person Type